LivaNova Enters into Definitive Agreement to Divest Its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation

March 8, 2018 by Website Admin in

LivaNova announced that it has entered into a definitive Purchase Agreement to divest its Cardiac Rhythm Management business franchise to MicroPort Scientific Corp.

Tweet

Share

Pin it

Previous StoryMoleculin to Present at the 30th Annual ROTH Conference Tuesday, March 13, 2018 Next StoryBellicum Announces Interim Results Showing Low Rates of Cancer Recurrence in Pediatric AML Patients Treated with BPX-501